Author Correction: Management of patients with advanced-stage HER2-positive breast cancer: current evidence and future perspectives
Authors and Affiliations
Division of New Drugs and Early Drug Development, European Institute of Oncology IRCCS, Milan, Italy
Antonio Marra
Human Oncology and Pathogenesis Program (HOPP), Memorial Sloan Kettering Cancer Center, New York, NY, USA
Sarat Chandarlapaty
Breast Medicine Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA
Sarat Chandarlapaty & Shanu Modi
Weill Cornell Medical College, New York, NY, USA
Sarat Chandarlapaty & Shanu Modi
Corresponding author
Correspondence to
Shanu Modi.
Comments (0)